Non-coding RNAs (ncRNAs), once considered the 'dark matter' of the genome, have now emerged as pivotal regulators in cancer ...

Patients with some gastrointestinal tumors were able to be treated with immunotherapy drugs alone and avoid surgery, ...

South Shore Health's Dr. Todd Ellerin says the drug, a form of immunotherapy, is not FDA-approved, but it is on a groundbreaking fast track.

Merck KGaA acquires SpringWorks Therapeutics, Inc. for $3.9B, boosting its pipeline with OGSIVEO & GOMEKLI. Click for more on ...

TLX101-CDx is an investigational positron emission tomography agent that targets the membrane transport proteins, LAT1 and LAT2.

Some people with early stage cancers may be able to skip surgery after being treated with the immunotherapy drug dostarlimab, ...

HonorHealth Research Institute's new downtown Phoenix laboratory has produced its first study, centered on a promising new ...

A world-first clinical trial launched in Melbourne is being hailed a ‘game-changer’ for its potential to revolutionize the ...

Spanios, a leader in human-derived organoid model systems, is pleased to announce a strategic partnership with White Lion ...

Researchers in South Korea have developed an organoid disease model and non-destructive stiffness analysis technology for ...

VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company”) announced that it has emerged from stealth mode to dramatically impact drug discovery and development. VivoSim will offer liver and intestinal ...